FDA Nominee Overton Faces Senate Questioning

Is there a risk that an ideologue is being handed the FDA or is Overton someone who will move the FDA in a positive direction?

Published 1 hour ago

FDA Nominee Overton Faces Senate Questioning

story

Above: Dr. Heidi Overton in Washington, D.C. on Sept. 24. Image credit: Tom Williams/CQ-Roll Call, Inc/Getty Images

The Spin

Democratic narrative

Overton has proven she's nothing more than a Trump loyalist and handing her the FDA would be a disaster for anyone who relies on safe medicine. A commissioner who already rejects the science on mifepristone can't be trusted to report honest findings or resist pressure to bury them. Her resistance to publicly criticizing the president causes worries about how she would handle all of her FDA responsibilities.

Patty Murray on X Bluesky Social Raw Story

Katie Phang on Youtube

Republican narrative

Overton must be confirmed. America's lead in biotechnology is slipping while an outdated FDA bureaucracy slows the cures patients need right now. A physician who has already helped strip an outdated warning off hormone therapy and push honest guidance on chronic disease is exactly the kind of leader who treats people like adults. Delay here is a gift to competitors and a loss for families waiting on treatment.

America First Policy Institute The Washington Times